Home » Newsletters » The Carlat Child Psychiatry Report

The Carlat Child Psychiatry Report

Depression in Children and Adolescents (May/June/July/August) | 2019

View Archived Issues

Learning Objectives, Depression in Children and Adolescents, CCPR, May/June/July/August 2019

June 11, 2019

After reading these articles, you should be able to… Read More

Note From the Editor-in-Chief

June 26, 2019

Joshua Feder, MD

In this double issue, we tackle a range of questions. First, does TMS help kids and teens with depression? Is it safe? Since many clinics are advertising TMS, we thought it was worth a close look. Read More

Medications for Depression

June 11, 2019

Martha J. Ignaszewski, MD

In this QA, we review the findings of placebo- controlled trials done over the past 10 years on depression in kids and the discuss the current recommendations for medication treatment of depression in children and adolescents. Read More

Practical Approaches to Vetting Clinical Research

June 11, 2019

Darren B. Courtney, MD, FRCPC

In this QA, we discuss how to use the PICOT method to efficiently frame the clinical questions that arise in everyday practice. We also examine the hierarchy in terms of the types of studies that are most useful for the busy clinician to look at and provide a corresponding table covering the categories of evidence for clinical practice. Read More

FDA Approves Adhansia XR

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

In this article we discuss a newly FDA-approved formulation for ADHD. Adhansia XR, is a new formulation of extended-release methylphenidate approved by the FDA for the treatment of ADHD in patients 6 years and older. Read More

First Non-Drug Treatment Approved by FDA for Treating Children With ADHD

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

In the article we discuss the effectiveness and safety of the first non-drug treatment for ADHD in kids. The FDA has recently granted medical device approval for its external Monarch Trigeminal Nerve Stimulation (eTNS) System for treating kids with ADHD ages 7–12 who are not currently taking medications. Read More

Prescribing Patterns for Children With Anxiety Disorders

June 11, 2019

Pavan Madan, MD.

Anxiety disorders are some of the most common conditions we encounter in children and adolescents, and clinicians employ a variety of medications to treat them. This study examined prescribing patterns for the initial treatment of pediatric anxiety. Read More

Melatonin for Insomnia in Patients With Autism

June 11, 2019

Jess Levy, MD.

Treating sleep problems in youth with autism spectrum disorder (ASD) is tricky at best. One promising treatment is pediatric prolonged-release melatonin (PedPRM) sold under the name Slenyto. Read More

Steroid-Induced Psychosis in the Pediatric Population

June 11, 2019

Ahhan Nazeer, MD.

Although childhood psychosis is a rare disorder, an accurate diagnosis is crucial. This article analyzes the results of a 2019 case study of steroid-induced psychosis in a pediatric patient. Read More

Risk of Psychosis With Stimulants in ADHD Patients

June 11, 2019

Pavan Madan, MD

As of 2007, the FDA requires stimulant manufacturers to warn of possible psychosis with stimulant use. This article analyzes the results of a 2019 study comparing the risk of psychosis between methylphenidate and amphetamine classes of medications. Read More

Transcranial Magnetic Stimulation (TMS) for Depression in Children and Adolescents

June 11, 2019

With concerns about both safety and efficacy surrounding antidepressant use in children and adolescents, we are always looking for safe, effective treatments for our patients. Transcranial Stimulation (TMS) has been around for many years, and its use in youth is expanding. We examine the evidence of efficacy and potential side effects in youth and adolescent populations. Read More

CME Post-Test - Depression in Children and Adolescents, CCPR, Summer 2019

June 11, 2019

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 2 CME credits. Read More

Psychiatry Practice Boosters, Fourth Edition (2023)
Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

Child Psychiatry
Hidden Dangers: The Fentanyl Crisis and Teen Overdose Prevention
The Fentanyl overdose crisis is now one of the leading causes of death among adolescents, and it is happening in every corner of the country. Stay with us as we talk about the...
Listen now